MOSAIC IMMUNOENGINEERING, INC.

Other languages Mosaic ImmunoEngineering, Inc.

Equities

CPMV

US61945M1018

Delayed OTC Markets Other stock markets 10:50:17 2024-05-01 am EDT			5-day change	1st Jan Change
0.6 ^USD	+1.90%		+91.63%	0.00%

Apr. 19	Mosaic Immunoengineering, Inc. Announces Demise of Gloria Felcyn, Independent Director and Member of Audit Committee, Compensation Committee and Corporate Governance and Nominating Committee	CI
Apr. 15	Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mosaic Immunoengineering, Inc. Announces Demise of Gloria Felcyn, Independent Director and Member of Audit Committee, Compensation Committee and Corporate Governance and Nominating Committee	Apr. 19
Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15
Mosaic ImmunoEngineering, Inc. Receives Letter of Termination from CWRU	Mar. 28
Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03
Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Mosaic Immunoengineering, Inc. Announces Nicole Steinmetz, Ph.D., to Resign as A Member of the Board of Directors and Acting Chief Scientific Officer	23-05-03
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-02
Mosaic ImmunoEngineering Inc. Auditor Raises 'Going Concern' Doubt	23-03-01
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-01
Mosaic ImmunoEngineering Inc. Academic Collaborators Receives Grants Totaling $4.3 Million from NCI Focuses on its Novel Immuno-Oncology Platform	22-10-31
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-04
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10
Mosaic ImmunoEngineering Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-26
Mosaic ImmunoEngineering Inc. Auditor Raises 'Going Concern' Doubt	22-01-25
Mosaic Immunoengineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer